MMP9 and neuropathy: This astrocyte activation, contributing to the chronicity of pain, suggests that chemotherapy-induced MMP9 upregulation could similarly extend pain signals in CIPN, reinforcing the broad impact of MMP9 on both peripheral and central aspects of neuropathy.